medium6.1
CVE-2017-17678
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS).
Impact
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Affected products
| Vendor | Product | Affected versions |
|---|---|---|
| Bmc | Remedy Mid-Tier | Version 9.1 |
Weakness classification
References
- NVD record
- CVE.org record
- https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
- https://seclists.org/fulldisclosure/2017/Oct/52
- https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
- https://seclists.org/fulldisclosure/2017/Oct/52